Eevia Health accepted as partner in the FOOD 2.0 - ECOSYSTEM
Eevia Health Plc (”Eevia” or ”The Company”) has been accepted by Valio as an ecosystem partner in the FOOD 2.0 program supported by Business Finland.
Valio, a leading food and dairy company out of Finland, has accepted Eevia Health as a partner in a new extensive research, development and innovation ecosystem called Food 2.0. This program is funded by Business Finland. The goal of the program is to create a Finnish nature-smart food system in which growth, profitability and added value are built based on sustainable production. The duration of the program is five years.
Valio’s Food 2.0 project has been granted EUR 10 million funding in Business Finland’s challenge competition for leading companies. In addition, Business Finland is preparing to fund ecosystem projects on Food 2.0 roadmap with EUR 20 million. Valio’s role is to initiate and lead wide-ranging cooperation as well as research and development projects with its current and new partners.
Eevia Health is an expert in pharmacognosy, with a focus on polyphenol-rich extract products made from organic plant materials wild-harvested in Finnish and Swedish forest. Research results show remarkable effects in humans in areas such as cellular recycling and gut health (effect on the microbiome). Eevia’s production processes also yield significant side streams in the form of fibers, liquid sugars, and organic acids, that may be used in food applications. Eevia will focus on nutrient efficiency and the utilization of nutritionally valuable components of renewable and regenerative forest biomass in a zero-waste value chain of scientifically substantiated nature-smart products.
“By being in this ecosystem led by Valio, Eevia could identify possible applications for our products and side streams in food and beverage sector. We expect this partnership to open new, interesting avenues for our future R&D activities as well.” says Petri Lackman, CTO in Eevia Health.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested sustainably.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.
INFORMATION ABOUT EEVIA HEALTH PLC
Valio is a brand leader in Finland and a major player in the international dairy ingredients market. The company holds over 300 patents in 50 countries and has net sales of EUR 1.8 billion and is Finland’s biggest food exporter. Valio products are found in some 50 countries, including Sweden, the Baltics, USA and China, and account for 25% of Finland’s total food exports. Valio employs a total of 25,000 people at dairy farms and 4,000 professionals at Valio.
To learn more, please visit www.valio.fi or follow Valio on LinkedIn @Valio.
